The growth is majorly driven by the rising R&D spending in pharmaceutical companies, emerging cell culture technologies for cell-based vaccines, increasing demand for monoclonal antibodies, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on …
The Growth in breath analyzer market can primarily be attributed to factors such as alcohol and drug abuse, stringent government regulations and increasing use of breathalyzers in detecting various diseases Growth Drivers: Growing alcohol and drug abuse; In 2018, about 10,511 people in the US …
Introduction of global Computer Vision Healthcare Market: The intangible facts surrounding the key restraints, opportunities, & risks that are anticipated to affect the industry’s development during the forecast period are investigated in the Computer Vision Healthcare Market report (2022-2023). Other assessments, like supply & demand, …
Major Objectives Behind This Study: # To define, describe, and forecast the global apheresis market by product, technology, application, procedure, end user, and region. # To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges). # To analyze micro markets with respect to individual …
The growth of the Single use Bioreactors Market is mainly driven by the increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, …
Introduction of global Medical Imaging Workstations Market: The intangible facts surrounding the key restraints, opportunities, & risks that are anticipated to affect the industry’s development during the forecast period are investigated in the Medical Imaging Workstations Market report (2022-2023). Other assessments, like supply & demand, imports …
Major Objectives Behind This Study: # To define, describe, and forecast the global clinical trial supplies market based on type, therapeutic area, service, end user, phase, and region. # To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, and opportunities). # To forecast the size of the market segments with respect to four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. # To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market. # To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders. # To profile key market players and comprehensively analyze their service portfolios, market positions, and core competencies. # To track and analyze competitive developments such as acquisitions, service launches, expansions, partnerships, collaborations in the market. Recent Developments: # In April 2021, Thermo Fisher announced plans to acquire PPD for USD 17.4 billion to enhance its offerings in clinical research services and to support clinical trials. # In April 2021, Parexel collaborated with Veeva Systems to improve their clinical processes for clinical trial delivery and enhance Veeva’s cloud technology. Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059 Major Growth Driving Factors: Market growth is largely driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the growing number of clinical trials conducted globally. However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period. RESTRAINTS: High cost of drug development Drug discovery and development involve high costs due to the high attrition rate of drug candidates in development. Since R&D for some rare diseases is very challenging and requires a specific group of people to conduct a clinical trial, drug R&D processes can be prone to failure. Only 7 out of 100 cancer drugs that reach the clinical testing phase end up gaining regulatory approval; most drugs fail long before this point. From drug discovery through FDA approval, developing a new medicine, on average, takes 10–15 years and costs USD 2.6 billion. Less than 12% of candidates that make it to Phase I clinical trials are approved by the FDA. This is a key factor limiting the growth of the market. OPPORTUNITY: R&D investments offer significant opportunities for the market North America and Europe, traditionally the major hubs for clinical trials, are facing challenges in terms of trial costs and patient pools. Recent health reforms in the US, the patent expiry of blockbuster drugs, and the global economic slowdown have affected the profitability of pharmaceutical companies. This is compelling several pharmaceutical companies to look for opportunities in emerging countries across the APAC, such as India, Singapore, South Korea, and China, which offer advantages such as reduced costs and easy access to a large heterogeneous patient population. Collaborations or expansions between companies in this market indicate that they are moving towards emerging markets to help their clients reduce the overall time consumed in clinical trials, thereby reducing their overall cost and resulting in the earlier launch of products in the market (post regulatory clearance). CROs can exploit these opportunities by supporting pharmaceutical companies to fulfill their needs for clinical trial supplies. End Users: The pharmaceutical and biotechnology companies segment accounted for the largest share in 2020 Based on end users, the clinical trial supplies market is categorized into three segments—pharmaceutical & biotechnology companies, contract research organizations (CROs), and medical device companies. The pharmaceutical and biotechnology companies accounted for the largest share of 70% of this market in 2020. This share is attributed to the rising R&D efforts by these companies. Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059 Geographical Growth Dynamics: North America was the largest regional market for clinical trial supplies in 2020. Geographically, the market is segmented into North America, Europe, Asia Pacific, RoW. In 2020, North America accounted for the largest share of the clinical trial supplies market, followed by Europe & Asia Pacific. The growing number of registered clinical trials and significant investments in R&D for clinical trials in this region are major factors driving the growth of the North American market. The presence of many global pharmaceutical giants, such as Pfizer, Abbott Laboratories, and Johnson & Johnson (which outsource their clinical trials to reduce the costs and time associated with completing these trials) in this region is another key driver for market growth. Projected Surge in Revenue Generation: The global clinical trial supplies market is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026.
The Protein Crystallization Market is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period. Protein Crystallization & Crystallography Market and Top technologies : X-ray crystallography – XRC is a widely used technology for protein …
The Global Rapid Microbiology Testing Market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4%. Driver: Increasing incidence of infectious disease and cancer; The incidence of various infectious diseases such as HIV, tuberculosis, malaria, and pneumonia …
This report aims to provide detailed insights into the global Dairy Herd Management Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the …
Major Objectives of this Study: # To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region. # To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges). # To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market. # To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players. # To estimate the market size and growth potential of the market segments with respect to five key regions-North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. # To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies. # To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market. # To benchmark players in the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering. Major Growth Driving Factors: Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915 Restraint: High cost of organ transplantation Organ transplantation is a resource-intensive procedure involving highly paid doctors and surgeons, expensive transportation, and pricey drugs that make it expensive. The charges associated with inpatient care, organ procurement, preservation, post-operative recipient care, and anti-rejection medication increase the overall cost. Patients also need to incur additional costs of traveling, lodging, meals, hospital visits, and other medical testing expenditures for evaluation or follow-ups scheduled at the transplant center for an advised time period of medical supervision. For low-income patients, such expenses directly compete with expenditure on necessities such as food, clothing, and shelter, which often renders organ transplantation procedures inaccessible without external aid. Challenge: Significant gap between the number of organs donated and organs required annually Currently, there is a significant gap between the number of organs donated and the number of organs required. In the US, the total number of patients on the waiting list for organs was over 100,000 (106,588 as of January 2022). Only 41,354 transplants were performed by the end of 2021 (Source: Organ Procurement and Transplantation Network, US). The limited number of organs donated annually is mainly due to a lack of awareness related to organ donation, poor legislative measures, and the increased risk of organ trafficking. Governments of various countries are also implementing reformed laws (such as opt-out laws that presume every citizen is an organ donor except for some exempted conditions) and initiatives to encourage people to donate organs. Opportunity: Growing healthcare investments Governments across the globe are focusing on strengthening their healthcare infrastructures to provide enhanced healthcare facilities. For example, in India, the Brihanmumbai Municipal Corporation allocated nearly USD 924 million (INR 7,000 crore) or 15% of its 2022–2023 budget to upgrade health services and establish 100 health centers with more than 100 diagnostic tests for preventive and primary treatment in BMC areas. These infrastructural developments will lead to an increased number of hospitals that treat more brain-dead patients who might be suitable donors. The increasing number of testing laboratories will also improve the time concerned with donor-recipient cross-matching, subject profiling, genotyping, and other related diagnostic tests during the pre-transplantation period. These developments are expected to create new opportunities for the organ preservation market. Recent Developments in the Global Organ Preservation Market: # In 2021, Paragonix Technologies launched the LIVERguard Donor Liver Preservation System in both the US and Europe. This strategy expanded Paragonixs’ product offerings and strengthened their geographic presence. # In 2021, XVIVO Perfusion partnered with Contatti Medical (Brazil) to expand its business and gain access to a comprehensive network of transplantation centers in Latin America’s largest country, Brazil. # In 2021, Institut Georges Lopez (Igl) (France) expanded its presence by setting up a manufacturing facility in Cheyyar, Tamil Nadu, India, for manufacturing medical devices and solutions for flushing and preservation of organs. # In 2021, Transmedics received premarket approval from the FDA for the OCS Heart System to be used with organs from donors after brain death (DBD). # In 2020, Dr. Franz Köhler Chemie GmbH (Germany) entered into a joint venture with Melchers Group and CICEL (Germany) to establish Köhler Pharmaceuticals (Beijing) Ltd. in China for the distribution of Custodiol HTK solutions for cardiac and transplant surgery in the Chinese market. Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915 Geographical Growth Dynamics: North America accounted for the largest share of the organ preservation market in 2020 In 2020, North America accounted for the largest share of the market, followed by the Asia Pacific, Europe, Latin America, and the Middle East & Africa. The large share of this region can be attributed to factors such as the growing demand for and adoption of organ transplantation as a result of the rising number of chronic diseases such as end-stage diseases. The need for preservation solutions to protect the viability of organs in ex-vivo environments in the region is also a key factor contributing to the large share of North America in the organ preservation market. End Users: The organ transplant centers segment accounted for the largest share of the organ preservation market in 2020 Based on end user, the market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment accounted for the largest share of the organ preservation market in 2020. The increasing number of transplant centers across the globe is the key factor driving the acceptance of this end-user segment and propelling the market growth.
The medical device cleaning market is one that keeps on growing, with more and more innovations being made in a year to combat germs and bacteria. The number of devices that require regular cleaning is rising, but so are the costs associated with their upkeep. …
This report aims to provide detailed insights into the global safe patient handling equipment market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players …
The study involved four major activities in estimating the current size for Infrared spectroscopy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the …